Section Arrow
SLDB.NASDAQ
- Solid Biosciences
Quotes are at least 15-min delayed:2026/04/22 14:59 EDT
Regular Hours
Last
 8.28
+0.12 (+1.47%)
Day High 
8.4 
Prev. Close
8.16 
1-M High
8.8661 
Volume 
519.07K 
Bid
8.27
Ask
8.29
Day Low
8.06 
Open
8.24 
1-M Low
6.4 
Market Cap 
802.87M 
Currency 美元 
P/E -- 
%Yield -- 
10-SMA 8.28 
20-SMA 7.78 
50-SMA 7.1 
52-W High 8.8661 
52-W Low 2.41 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-1.99/-1.36
Enterprise Value
821.93M
Balance Sheet
Book Value Per Share
1.83
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
0
Operating Revenue Per Share
--
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
IOVAIovance Biotherapeutics3.465-0.235-6.35%-- 
ASBPAspire Biopharma Holdings Inc.0.2244+0.0276+14.02%-- 
TOVXTheriva Biologics Inc0.3765+0.0378+11.16%0.09PE
REPLReplimune Group2.175+0.315+16.94%-- 
GERNGeron Corp1.54+0.04+2.67%-- 
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
Solid Biosciences Inc is a life sciences company focused on advancing a portfolio of current and future gene therapy candidates, including SGT-003 for the treatment of Duchenne muscular dystrophy, SGT-212 for the treatment of Friedreich's ataxia, SGT-501 for the treatment of catecholaminergic polymorphic ventricular tachycardia, SGT-601 for the treatment of TNNT2-mediated dilated cardiomyopathy, and additional assets for the treatment of genetic cardiac and neuromuscular diseases. The majority of its current programs are designed to treat these diseases with gene transfer products. The company operates in a single segment, developing treatments through gene therapy and other means for patients with neuromuscular and cardiac diseases.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.